4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Intracranial atheroSclErosis With Repatha Repatha - Ischemic Stroke | Phase 4 | Terminated | University of California, Los Angeles | 10 | 2021-04-23 | 2023-03-15 |
| Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis Oral Anticoagulant, Antiplatelet Drug - Ischemic Stroke, Atrial Fibrillation | Phase 4 | Terminated | National Hospital Organization Osaka National Hospital | 321 | 2017-04-06 | 2024-12-27 |
| Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study Glycerna, Jevity - Control Diet - Subarachnoid Hemorrhage, Intracranial Hemorrhage | Phase 4 | Terminated | Eastern Virginia Medical School | 14 | 2011-11-01 | 2012-10-05 |
| Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke Dextro-Amphetamin, Glucose - Stroke | Phase 4 | Terminated | Reha Rheinfelden | 16 | 2001-01-01 | 2007-12-13 |
Atrial Fibrillation (1) · Hematoma, Subdural (1) · Intracranial Arteriosclerosis (1) · Intracranial Hemorrhages (1) · Stroke (1) · Subarachnoid Hemorrhage (1) · Thrombosis (1)
Brain Diseases (4) · Cardiovascular Diseases (4) · Central Nervous System Diseases (4) · Cerebrovascular Disorders (4) · Nervous System Diseases (4) · Vascular Diseases (4) · Stroke (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arrhythmias, Cardiac (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Craniocerebral Trauma (1) · Embolism and Thrombosis (1) · Heart Diseases (1)
Anticoagulants (1) · Glucose (1) · Platelet Aggregation Inhibitors (1) · evolocumab (1)
Eastern Virginia Medical School (1) · National Hospital Organization Osaka National Hospital (1) · Reha Rheinfelden (1) · University of California, Los Angeles (1)
United States (2) · Japan (1) · Switzerland (1)
Hiroshi Yamagami, MD (1) · Thierry M. Ettlin, Prof. (1)